Markets
markets

Nintendo’s Switch 2 sales are outpacing the original Switch by ~2x

After a booming first month in which it sold 5.82 million Switch 2s, Nintendo on Tuesday reported that it has now sold 10.36 million units of the handheld consoles through September.

That’s well ahead of the original Switch’s pace at the same period in its lifetime — the first Switch model sold 4.7 million units through its first four months, though it went on to become one of the company’s all-time console sales leaders (it’s just a few thousand units short of the Nintendo DS). The Switch 2’s pace in four months has it just 3.2 million units shy of the lifetime sales of the Wii U.

Nintendo appears to be growing more confident in the Switch 2, despite US tariffs. Last month, the company boosted its annual production target to 25 million units by the end of March 2026, according to reporting by Bloomberg.

The new data came as the Japanese gaming giant reported its first-half earnings on Tuesday. Nintendo posted ~$3.6 billion in sales for the three months that ended in September, topping the $3.04 billion expected by analysts polled by Bloomberg.

The company also hiked its full-year guidance to a revenue of ~$14.6 billion, as well as its expectations for Switch 2 sales. The company now anticipates selling 19 million units compared with 15 million units projected previously. Despite the news, Nintendo’s US-traded ADRs were relatively flat in after-hours trading on Monday, suggesting elevated expectations into the print.

More Markets

See all Markets
markets

Broadcom soars on Google’s plans for up to $185 billion in capex this year

Google’s capex guidance is Broadcom’s earnings guidance.

The hyperscaler and search giant said its 2026 capex budget would be between $175 billion and $185 billion, 55% higher than the street anticipated.

Accordingly, shares of the custom chip specialist are soaring in after-hours trading.

Broadcom has enjoyed a halo effect from Google’s capex plans and the success of its Gemini 3 model (trained on TPUs the two companies co-designed) over the past year.

But the custom chip designer had tumbled after its most recent earnings report, with some analysts attributing the decline to the dearth of new customer announcements. But who needs new customers when your current ones are opening their wallets this much?!?

Accordingly, shares of the custom chip specialist are soaring in after-hours trading.

Broadcom has enjoyed a halo effect from Google’s capex plans and the success of its Gemini 3 model (trained on TPUs the two companies co-designed) over the past year.

But the custom chip designer had tumbled after its most recent earnings report, with some analysts attributing the decline to the dearth of new customer announcements. But who needs new customers when your current ones are opening their wallets this much?!?

(J. Edward Moreno/Sherwood News)

Novo and Lilly agree prices are falling — and disagree on what comes next

Novo Nordisk and Eli Lilly are cutting prices to reach more patients — with sharply different expectations about what that means for sales.

markets

Ozempic is no longer the most searched for GLP-1 in the US

Ozempic, the popular diabetes drug made by Novo Nordisk, used to be shorthand for an entire class of diabetes and weight-loss medications. Not anymore.

According to Google Trends data, as of January, more people in the US are searching for Eli Lilly’s weight-loss shot, Zepbound, than Ozempic. At the same time, interest in the word “Ozempic” now sits roughly on par with searches for “peptides,” a catchall term for a booming, loosely regulated category of experimental supplements.

The numbers hint at a cultural shift: Ozempic is no longer the only word people reach for when they think about weight-loss drugs. The market — and the vocabulary around it — is fragmenting.

This shift also reflected in sales numbers. For several quarters now, Lillys diabetes and weight-loss drugs have outsold Novos, and that gap is expected to widen this year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.